Clinical Trial

Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 16, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
Protocol Amendment History 13 amendments
This ClinicalTrials.gov record has been amended 13 times since 2011-09-06; most recent amendment 2024-10-11.
Trial Details
NCT Number NCT01429389
Lead Sponsor Sequenom, Inc.
Conditions Down Syndrome, Fetal Aneuploidy
Enrollment 2,000 participants
Start Date 2011-05
Primary Completion 2025-12 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2024-10-16